STA-5326 in Crohn's Disease Patients

Clinical trial NCT00088062 · COMPLETED

Trial details

NCT number: NCT00088062
Sponsor: Synta Pharmaceuticals Corp.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Crohn's Disease

Start date: 2004-02-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.